Used in the pharmaceutical industry as an intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. It plays a role in developing drugs that modulate signaling pathways involved in tumor growth and progression. Due to its fluorinated and nitrile-containing structure, it enhances binding selectivity and metabolic stability in active pharmaceutical ingredients. Commonly employed in research settings for structure-activity relationship studies in oncology drug development.